Last viewed:
PTE
Prices are updated after-hours
PTE
|
$0.241
-0.82%
-6.68%
0
|
Consumer Durables
(0.0% 1d)
(0.0% 1m)
(-47.5% 1y)
(0.0% 2d)
(0.0% 3d)
(0.0% 7d)
(261.85%
volume)
Earnings Calendar: 2023-03-29
Market Cap: $ 1,777,672
http://www.polarityte.com
Sec
Filling
|
Patents
| 157 employees
(US) PolarityTE, Inc. is a biotechnology company developing and commercializing regenerative tissue products and biomaterials. The firm products include SkinTE Cryo, SkinTE POC, PTE 11000, OsteoTE and Real Time Assistant. Its SkinTE product is commercially available for the repair, reconstruction, replacement, and supplementation of skin in patients who have a need for treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. The company was founded on May 8, 1998 and is headquartered in Salt Lake City, UT.
skin
cryo
treatment
add to watch list
Paper trade
email alert is off
Press-releases
Insights into the Global Autologous Wound Patches Market: Drivers, Restraints, Opportunities and Challenges 2023 to 2030
Published: 2023-08-16
(Crawled : 16:00)
- prnewswire.com
PTE
|
$0.241
-0.82%
-6.68%
0
|
Consumer Durables
| Email alert
Add to watchlist
AURX
4
|
$0.95
116.67%
1K
|
| Email alert
Add to watchlist
global
Delisting of Securities of Puhui Wealth Investment Management Co., Ltd.; National Energy Services Reunited Corp.; Bed Bath & Beyond Inc.; IMV Inc.; Celyad Oncology SA; Aptinyx Inc.; Athenex, Inc.; Greencity Acquisition Corporation; QualTek Services Inc.; Bellicum Pharmaceuticals, Inc.; Wejo Group Limited; Cyxtera Technologies, Inc.; HTG Molecular Diagnostics, Inc.; Unico American Corporation; PolarityTE, Inc.; Oncorus, Inc.; and OncoSec Medical Incorporated from The Nasdaq Stock Market
Published: 2023-07-06
(Crawled : 20:00)
- globenewswire.com
ONCSQ
|
$0.0001
43900.0%
820
|
Manufacturing
| -99.89%
| O: -15.79%
H: 12.5%
C: -6.25%
CYXTQ
|
$0.0007
-57.14%
1.8K
|
| -98.71%
| O: -4.89%
H: 17.73%
C: -5.28%
QTEKQ
|
$0.012
125.0%
640K
|
Construction
| -36.36%
| O: -17.88%
H: 11.07%
C: -0.37%
ATNXQ
|
$0.0152
-85.53%
3.6K
|
Manufacturing
| -86.19%
| O: 54.31%
H: 0.0%
C: -29.37%
IMVIQ
|
$0.0001
36400.0%
6K
|
Manufacturing
| -100.0%
| O: -18.75%
H: 192.31%
C: 32.62%
ONCR
|
$0.126
-75.95%
140K
|
Health Technology
| 196.13%
| O: -2.05%
H: 29.3%
C: 0.0%
NESR
|
$9.2
-36.31%
68K
|
Industrial Services
| 206.67%
| O: 0.0%
H: 0.0%
C: 0.0%
NDAQ
|
$61.095
-0.17%
-0.17%
2.3M
|
Finance
| 24.92%
| O: -0.22%
H: 0.8%
C: 0.18%
BLCM
|
$0.0748
381.28%
6.1K
|
Health Technology
| -79.78%
| O: -14.11%
H: 7.11%
C: 6.2%
management
nasdaq
energy
services
beyond
group
acquisition
medical
molecular
market
PolarityTE Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-10
(Crawled : 22:00)
- prnewswire.com
PTE
|
$0.241
-0.82%
-6.68%
0
|
Consumer Durables
| Email alert
Add to watchlist
financial
update
results
PolarityTE to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14, 2022
Published: 2022-09-13
(Crawled : 13:20)
- biospace.com/
PTE
|
$0.241
-0.82%
-6.68%
0
|
Consumer Durables
| -74.0%
| O: 0.35%
H: 13.98%
C: 8.06%
global
conference
PolarityTE to Report Q2 2022 Financial Results on August 11, 2022
Published: 2022-08-01
(Crawled : 14:00)
- biospace.com/
PTE
|
$0.241
-0.82%
-6.68%
0
|
Consumer Durables
| -82.01%
| O: 0.0%
H: 1.49%
C: 0.75%
report
results
PolarityTE Announces $8.0 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules
Published: 2022-06-06
(Crawled : 12:20)
- prnewswire.com
PTE
|
$0.241
-0.82%
-6.68%
0
|
Consumer Durables
| -90.08%
| O: -1.65%
H: 2.51%
C: -9.21%
nasdaq
PolarityTE Reports First Quarter 2022 Financial Results and Provides Business Update
Published: 2022-05-16
(Crawled : 12:00)
- prnewswire.com
PTE
|
$0.241
-0.82%
-6.68%
0
|
Consumer Durables
| -9.23%
| O: 1599.62%
H: 4.16%
C: -5.48%
results
PolarityTE Announces FDA Regenerative Medicine Advanced Therapy Designation Granted to SkinTE®
Published: 2022-05-13
(Crawled : 12:20)
- biospace.com/
PTE
|
$0.241
-0.82%
-6.68%
0
|
Consumer Durables
| 74.64%
| O: 92.39%
H: 0.0%
C: 0.0%
skinte
fda
designation
granted
therapy
grant
PolarityTE to Report Q1 2021 Financial Results on May 16, 2022
Published: 2022-05-06
(Crawled : 12:20)
- prnewswire.com
PTE
|
$0.241
-0.82%
-6.68%
0
|
Consumer Durables
| 32.56%
| O: 3.96%
H: 0.53%
C: -7.94%
report
results
PolarityTE Announces First Subject Enrolled in Phase III Pivotal Study Evaluating Investigational New Drug SkinTE® in Diabetic Foot Ulcers
Published: 2022-05-03
(Crawled : 18:00)
- biospace.com/
PTE
|
$0.241
-0.82%
-6.68%
0
|
Consumer Durables
| 31.77%
| O: -1.04%
H: 14.36%
C: 3.87%
skinte
drug
diabetic
enroll
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount